Le Lézard
Classified in: Health, Covid-19 virus
Subject: FVT

GALAXY Medical CENTAURI PEF System to be Displayed at AF Symposium Recorded Case Presentation


SAN CARLOS, Calif., Jan. 21, 2021 /PRNewswire/ -- Galaxy Medical, a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the proprietary CENTAURItm System will be featured in a recorded case presentation on Sunday January 31st during the upcoming AF Symposium.

Ante Anic?, EP Lab Director at University Hospital Split and the Primary Investigator of the ECLIPSE-AF study, will be presenting the case which was completed as part of the ECLIPSE-AF study. Dr. Anic? said: "The Galaxy Medical CENTAURI System has performed extremely well during the first 32 cases we have completed at our center and we felt this was a unique opportunity to share our experience with the EP community."

The CENTAURI System is uniquely designed as an open energy platform with proprietary interface hardware and waveform control algorithms, which enable electrophysiologists to continue with the established point-by-point clinical workflow used in the majority of cardiac ablation procedures worldwide. Centauri offers the enhanced features of PEF energy without the typical learning curve and workflow adjustments associated with new technologies.

Key features of the Centauri System:

Jonathan Waldstreicher, MD, CEO of Galaxy Medical commented: "We are pleased to collaborate with Dr. Anic? in sharing our experience with the EP community at such a prominent event. Our ECLIPSE-AF trial has enrolled 47 patients in Split, Croatia and Hasselt, Belgium despite the challenges relating to COVID-19, demonstrating the seamless transition to this technology. We look forward to moving to the next phases of development in Europe and the United States to study the safety and efficacy of CENTAURI in comparison to currently marketed technologies."

The Centauri System is an investigational device and not approved for commercial use.

About Galaxy Medical
Galaxy Medical is a privately held medical device company based in San Carlos, CA, that is dedicated to developing therapies to treating patients with cardiac arrhythmias. Formed by Apple Tree Partners, a healthcare-focused venture capital firm based in New York, Galaxy is building a portfolio of technologies to address the needs of cardiac electrophysiologists.

Media Contact:
Michael Iversen
[email protected]
M:520.400.9190
www.galaxymed.com

SOURCE Galaxy Medical


These press releases may also interest you

at 16:32
The wishes that Make-A-Wish grants wouldn't be possible without the support of countless "WishMakers" such as donors, volunteers, corporate partners, community advocates and more. "WishMakers" ? a term for anyone who steps up to take action...

at 16:30
Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, announced a new appointment to the Canadian Centre on Substance Use and Addiction (CCSA) Board of Directors. Scott Elliott is appointed as...

at 16:28
The Rett Syndrome Research Trust (RSRT) is proud to announce its partnership with PMD Solutions, a leading provider of innovative healthcare technologies, in their upcoming biosensor validation study called VIBRANT. PMD Solutions will generously...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the fourth quarter and full year ended December 31,...

at 16:20
AN2 Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today reported financial results for the fourth quarter and year ended...

at 16:20
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that its Board of Directors has unanimously approved plans to initiate a rights offering. The...



News published on and distributed by: